Abstract
Optogenetic techniques allow versatile, cell type-specific light-based control of cellular activity in diverse set of cells, circuits, and brain structures. Optogenetic actuators are genetically encoded light-sensitive membrane proteins that can be selectively introduced into cellular circuits in the living brain using a variety of genetic approaches. Gene targeting approaches used in optogenetic studies vary greatly in their specificity, their spatial coverage, the level of transgene expression and their potential adverse effects on neuronal cell health. Here, we describe the major gene targeting approaches utilized in optogenetics and provide a simple set of guidelines through which these approaches can be evaluated when designing an in vitro or in vivo optogenetic study.
Original language | English |
---|---|
Title of host publication | Neuromethods:A Roadmap |
Pages | 25-42 |
Number of pages | 18 |
ISBN (Electronic) | 9781493974177 |
DOIs | |
Publication status | Published Online - 25 Oct 2017 |
Publication series
Series | Neuromethods |
---|---|
Volume | 133 |
ISSN | 0893-2336 |
Bibliographical note
We thank all members of the Yizhar and Tidis labs for their helpful comments on the manuscript. We thank K. Deisseroth and L. de Lecea for mentoring our early steps in optogenetics. O.Y. is supported by grants from the Israel Science Foundation (#1351/12), the European Research Commission (ERC starting grant #337637 and Marie Curie Actions grant #321919) and the Israeli Ministry ofScience, and Technology and Space (grant #10373). A.A. is supported by the Human Frontier Science Program (RGY0076/2012), the Swiss National Science Foundation (grant #156156), the Inselspital, the University of Bern and the European Research Commission (ERC Consolidator grant).